This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
The genus Akkermansia is populated by a multitude of biological species with a wide distribution in the animal kingdom
Biology Direct Open Access 24 July 2025
-
Dietary ellagic acid therapy for CNS autoimmunity: Targeting on Alloprevotella rava and propionate metabolism
Microbiome Open Access 24 June 2024
-
Immunomodulating effects of the single bacterial strain therapy EDP1815 on innate and adaptive immune challenge responses — a randomized, placebo-controlled clinical trial
Immunologic Research Open Access 15 May 2024
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$32.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$189.00 per year
only $15.75 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Baranzini, S. E. et al. Gut bacteria from multiple sclerosis patients modulate human T cells and exacerbate symptoms in mouse models. Proc. Natl Acad. Sci. USA http://dx.doi.org/10.1073/pnas.1711235114 (2017)
Wekerle, H. et al. Gut microbiota from multiple sclerosis patients enables spontaneous autoimmune encephalomyelitis in mice. Proc. Natl Acad. Sci. USA http://dx.doi.org/10.1073/pnas.1711233114 (2017)
Related links
Related links in Nature Research
Rights and permissions
About this article
Cite this article
Hindson, J. A possible link between multiple sclerosis and gut microbiota. Nat Rev Neurol 13, 705 (2017). https://doi.org/10.1038/nrneurol.2017.142
Published:
Issue date:
DOI: https://doi.org/10.1038/nrneurol.2017.142
This article is cited by
-
The genus Akkermansia is populated by a multitude of biological species with a wide distribution in the animal kingdom
Biology Direct (2025)
-
Dietary ellagic acid therapy for CNS autoimmunity: Targeting on Alloprevotella rava and propionate metabolism
Microbiome (2024)
-
Immunomodulating effects of the single bacterial strain therapy EDP1815 on innate and adaptive immune challenge responses — a randomized, placebo-controlled clinical trial
Immunologic Research (2024)